Crossmark

Early Nirsevimab Administration During Hospitalization for RSV Bronchiolitis may Reduce Disease Severity in Non-immunized infants: A Descriptive Study

Crossref DOI link: https://doi.org/10.1016/j.arbres.2025.06.010

Published Print: 2025-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Méndez-Echevarria, Ana

Soler-Simón, Jose Antonio

Simón Carro, Eva

Flores Pérez, Patricia

Jiménez García, Raquel

Sánchez-Rico Lucas-Torres, Begoña

Tejada Pérez, María

Alcolea, Sonia

García-García, María Luz

Baquero-Artigao, Fernando

Calvo, Cristina
License Information

Text and Data Mining valid from 2025-12-01

Text and Data Mining valid from 2025-12-01
More Information

This article is maintained by: Elsevier

Article Title: Early Nirsevimab Administration During Hospitalization for RSV Bronchiolitis may Reduce Disease Severity in Non-immunized infants: A Descriptive Study

Journal Title: Archivos de Bronconeumología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.arbres.2025.06.010

Content Type: simple-article

Copyright: © 2025 SEPAR. Published by Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Document is current

Any future updates will be listed below